Findings on pancreatic cancer could improve immunotherapies
Researchers have revealed the immune landscape and microbiome of pancreatic cysts as they progress to pancreatic cancer, providing targets for immunotherapy.
List view / Grid view
Researchers have revealed the immune landscape and microbiome of pancreatic cysts as they progress to pancreatic cancer, providing targets for immunotherapy.
Researchers have developed a 3D structure that allows them to see how and where disease mutations on the twinkle protein can lead to mitochondrial diseases.
The new mouse embryo model system promises to spur research into developmental health and disease.
New study finds that using CRISPR to block RASA2 gene makes T cells more resilient against cancer.
Scientists have discovered adenosine could inhibit CD39, a molecule that suppresses the immune system.
Researchers have discovered a way to ignite T cells, potentially increasing the scope and success of T cell-based immunotherapy.
The study describes how oncolytic virotherapy can work with existing immunotherapy techniques, boosting the immune capacity to effectively target and destroy cancer cells.
31 August 2022 | By Eurofins Discovery
Watch our on-demand webinar where our expert speaker will explore the possibilities for designing selective small molecules targeting the SH2 domains of STAT proteins plus more.
Researchers have found that blocking key enzymes could boost anti-cancer T cell responses and resistance to immunosuppression.
Scientists have discovered antibodies that are effective against many different COVID-19 variants.
Application note: Quantifying T Cell response in 3D tumour spheroids using advanced flow cytometry workflows.
Vaccinating mice with this universal flu candidate induced broad neuraminidase inhibition, M2 ectodomain specific antibodies and T cell immune responses.
Researchers have developed a safe and versatile platform to increase the thermal stability of vaccines and improve their transportability.
Researchers have designed a COVID-19 vaccine to be less sensitive to mutations and equipped for future strains.
Scientists have found that unconventional T cells migrate from tissue into the lymph nodes and influence immune responses there.